Streetbeat News

CMRA

Comera Life Sciences Holdings Inc

Industry

Research and Development in Biotechnology

Open

0.00

Mkt cap

3.1K

Volume

12K

High

0.00

P/E Ratio

N/A

52-wk high

0.13

Low

0.00

Div yield

N/A

52-wk low

0.00

The article reports on the stock movements in Thursday's mid-day session. Notable gainers include MSP Recovery, Near Intelligence, Murphy Canyon Acquisition, TradeUP Acquisition, Neptune Wellness, Inspire Veterinary Partners, Splunk, Solowin Holdings, AgriFORCE Growing Systems, Movella Holdings, Safe & Green Holdings, The Dixie Group, Calliditas Therapeutics, Applied Molecular Transport, Ainos, and Exscientia. Notable losers include Travere Therapeutics, Seelos Therapeutics, QuantaSing Group, Cazoo Group, Cheche Group, Comera Life Sciences, Mondee Holdings, TKO Group Holdings, Opendoor Technologies, TransCode Therapeutics, LanzaTech Global, WM Technology, CF Acquisition, WW International, ZipRecruiter, 36Kr Holdings, Evotec, Avinger, fuboTV, Affirm Holdings, Charles River Laboratories, Elutia, and Broadcom.

Portfolio Pulse from Lisa Levin

September 21, 2023 | 5:16 pm

In Tuesday's after-market session, several healthcare stocks saw significant movement. Rocket Pharmaceuticals (RCKT) rose 29.6%, Applied Molecular (AMTI) increased by 9.5%, Modular Medical (MODD) increased by 8.1%, Codexis (CDXS) rose 7.99%, Comera Life Sciences (CMRA) moved upwards by 6.66%, and Hoth Therapeutics (HOTH) rose 6.34%. On the other hand, Eiger BioPharmaceuticals (EIGR) declined by 34.8%, IGC Pharma (IGC) decreased by 8.68%, Impel Pharmaceuticals (IMPL) decreased by 7.92%, Axcella Health (AXLA) declined by 7.02%, NeuBase Therapeutics (NBSE) decreased by 6.98%, and InnovAge Holding (INNV) decreased by 6.77%.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 9:31 pm

Several stocks experienced significant price movements in Tuesday's mid-day session. Tenon Medical withdrew its proposed public offering, causing its shares to climb 63.5%. Avalo Therapeutics agreed to divest AVTX-800 series, leading to a 52.6% gain. Cognyte Software reported better-than-expected Q2 results and issued FY24 guidance above estimates, resulting in a 24.8% gain. Xos was awarded a contract by the State of California, causing a 23% gain. The Beauty Health Company announced a business transformation program and a $100 million share repurchase, leading to a 16.6% jump. On the other hand, Acelyrin shares fell 60.8% after announcing disappointing trial results. CS Disco shares fell 22.1% after the company announced its CEO's departure.

Portfolio Pulse from Lisa Levin

September 12, 2023 | 5:44 pm

During Tuesday's intraday session, several healthcare stocks experienced significant movements. Gainers included Axcella Health (AXLA), Tenon Medical (TNON), Avalo Therapeutics (AVTX), Myomo (MYO), Cosmos Health (COSM), and Comera Life Sciences (CMRA). Losers included Sight Sciences (SGHT), Longeveron Inc. - Subscription Right (LGVNR), Orthofix Medical (OFIX), PAVmed (PAVM), NovaBay Pharmaceuticals (NBY), and Inspire Veterinary (IVP).

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 5:31 pm

During Thursday's pre-market session, several health care stocks experienced significant movement. Acer Therapeutics, Allarity Therapeutics, Longeveron, TransCode Therapeutics, Comera Life Sciences, and Femasys saw their stocks rise, with Acer Therapeutics leading the gainers with a 70.5% increase. On the other hand, Axcella Health, OKYO Pharma, Aptorum Gr, HeartBeam, Kazia Therapeutics, and Fortress Biotech saw their stocks decline, with Axcella Health leading the losers with a 21.5% decrease.

Portfolio Pulse from Benzinga Insights

August 31, 2023 | 1:06 pm

Comera Life Sciences has filed a prospectus for the offer and resale of 27,863,058 shares of common stock by selling stockholders.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2023 | 8:44 pm

During Tuesday's pre-market session, several health care stocks experienced significant movement. Axcella Health, Tivic Health Systems, Celularity, Shuttle Pharmaceuticals, Comera Life Sciences, and Bionomics saw increases in their share prices, with Axcella Health leading with a 222.2% increase. On the other hand, T2 Biosystems, YS Biopharma, Myomo, Enveric Biosciences, NeuroPace, and Novo Integrated Sciences experienced declines, with T2 Biosystems leading the decline with a 10.7% decrease.

Portfolio Pulse from Benzinga Insights

August 29, 2023 | 1:06 pm

During Monday's pre-market session, several health care stocks experienced significant movement. Bionomics, Geovax Labs, Tivic Health Systems, Outlook Therapeutics, Comera Life Sciences, and Societal CDMO saw increases in their stock prices, while NovoCure, Longeveron Inc. - Subscription Right, Myomo, Scilex Holding, Aptorum Gr, and Evaxion Biotech experienced decreases.

Portfolio Pulse from Benzinga Insights

August 28, 2023 | 1:06 pm

During Friday's pre-market session, several healthcare stocks experienced significant movement. YS Biopharma Co, Longeveron Inc., Comera Life Sciences, T2 Biosystems, Moleculin Biotech, and Omega Therapeutics saw their shares rise, while Myomo, Minerva Surgical, Pieris Pharmaceuticals, Alpha Tau Medical, NeuBase Therapeutics, and Vincerx Pharma saw their shares decline.

Portfolio Pulse from Benzinga Insights

August 25, 2023 | 1:06 pm

Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) has announced the publication of a study in the Journal of Pharmaceutical Sciences that supports the development of caffeine as a viscosity reducing agent for subcutaneous formulations of monoclonal antibodies. The study found that caffeine does not affect the pharmacokinetic profiles of the model monoclonal antibody and shows rapid absorption and elimination. The company plans to continue the development of caffeine as a viscosity reducing agent and expand its computational modeling tools to potentially include AI capabilities.

Portfolio Pulse from Happy Mohamed

August 16, 2023 | 12:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.